KROS
Price
$10.99
Change
+$0.34 (+3.19%)
Updated
Jun 22, 04:59 PM (EDT)
Capitalization
217.51M
51 days until earnings call
Intraday BUY SELL Signals
RKLB
Price
$99.68
Change
-$7.56 (-7.05%)
Updated
Jun 22, 04:16 PM (EDT)
Capitalization
67.01B
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KROS vs RKLB

KROS vs RKLB Comparison Chart in %
View a ticker or compare two or three
VS
KROS vs. RKLB commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a Hold and RKLB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (KROS: $10.65 vs. RKLB: $107.24)
Brand notoriety: KROS and RKLB are both not notable
KROS represents the Biotechnology, while RKLB is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: KROS: 135% vs. RKLB: 249%
Market capitalization -- KROS: $217.51M vs. RKLB: $62.66B
KROS [@Biotechnology] is valued at $217.51M. RKLB’s [@Aerospace & Defense] market capitalization is $62.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $2.04T to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B. The average market capitalization across the [@Aerospace & Defense] industry is $48.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 0 FA rating(s) are green whileRKLB’s FA Score has 1 green FA rating(s).

  • KROS’s FA Score: 0 green, 5 red.
  • RKLB’s FA Score: 1 green, 4 red.
According to our system of comparison, RKLB is a better buy in the long-term than KROS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 5 TA indicator(s) are bullish while RKLB’s TA Score has 3 bullish TA indicator(s).

  • KROS’s TA Score: 5 bullish, 5 bearish.
  • RKLB’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, KROS is a better buy in the short-term than RKLB.

Price Growth

KROS (@Biotechnology) experienced а +5.97% price change this week, while RKLB (@Aerospace & Defense) price change was -6.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.22%. For the same industry, the average monthly price growth was +2.50%, and the average quarterly price growth was +2212.17%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -3.36%. For the same industry, the average monthly price growth was -3.19%, and the average quarterly price growth was +15.24%.

Reported Earning Dates

KROS is expected to report earnings on Aug 12, 2026.

RKLB is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+5.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (-3.36% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RKLB($67B) has a higher market cap than KROS($218M). RKLB YTD gains are higher at: 53.727 vs. KROS (-47.692). KROS has higher annual earnings (EBITDA): -108.78M vs. RKLB (-140.1M). RKLB has more cash in the bank: 1.38B vs. KROS (281M). KROS has less debt than RKLB: KROS (16.3M) vs RKLB (139M). RKLB has higher revenues than KROS: RKLB (680M) vs KROS (33.2M).
KROSRKLBKROS / RKLB
Capitalization218M67B0%
EBITDA-108.78M-140.1M78%
Gain YTD-47.69253.727-89%
P/E Ratio4.78N/A-
Revenue33.2M680M5%
Total Cash281M1.38B20%
Total Debt16.3M139M12%
FUNDAMENTALS RATINGS
KROS: Fundamental Ratings
KROS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KROSRKLB
RSI
ODDS (%)
Bullish Trend 5 days ago
87%
Bearish Trend 5 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
87%
Momentum
ODDS (%)
Bearish Trend 5 days ago
70%
Bearish Trend 5 days ago
77%
MACD
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
77%
Bearish Trend 5 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 27 days ago
87%
Declines
ODDS (%)
Bearish Trend 15 days ago
77%
Bearish Trend 13 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
87%
Bullish Trend 5 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
KROS
Daily Signal:
Gain/Loss:
RKLB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HFWA27.920.40
+1.45%
Heritage Financial Corp
PESI11.000.12
+1.10%
Perma-Fix Environmental Services
PATH10.270.04
+0.39%
UiPath
BAFN4.96-0.07
-1.39%
BayFirst Financial Corp
CI279.27-5.82
-2.04%
Cigna Group (The)

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+2.31%
AXON - KROS
43%
Loosely correlated
+0.09%
MGTX - KROS
43%
Loosely correlated
+8.74%
AVBP - KROS
43%
Loosely correlated
+1.21%
XNCR - KROS
41%
Loosely correlated
-1.10%
RGNX - KROS
41%
Loosely correlated
-1.27%
More

RKLB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RKLB has been closely correlated with LUNR. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if RKLB jumps, then LUNR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RKLB
1D Price
Change %
RKLB100%
-0.69%
LUNR - RKLB
71%
Closely correlated
+0.57%
RDW - RKLB
63%
Loosely correlated
-0.07%
VOYG - RKLB
59%
Loosely correlated
-2.52%
PL - RKLB
58%
Loosely correlated
+0.04%
ACHR - RKLB
56%
Loosely correlated
+3.92%
More